Azithromycin Treatment Alters Gene Expression in Inflammatory, Lipid Metabolism, and Cell Cycle Pathways in Well-Differentiated Human Airway Epithelia
暂无分享,去创建一个
Richard C. Boucher | Wanda K. O'Neal | Yichao Wu | R. Boucher | B. Brighton | Carla Maria P. Ribeiro | Harry Hurd | Yichao Wu | Mary E. B. Martino | Lisa Jones | Brian Brighton | Harry L. Hurd | M. B. Martino | L. Jones | W. O’Neal | Carla M. P. Ribeiro
[1] D. Griffith,et al. The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages. , 2001, The Journal of antimicrobial chemotherapy.
[2] M. d’Yvoire,et al. Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin. , 1998, The Journal of antimicrobial chemotherapy.
[3] M. Parnham,et al. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. , 2005, European journal of pharmacology.
[4] A. Bush,et al. Anti‐inflammatory effects of macrolides in lung disease * , 2001, Pediatric pulmonology.
[5] B. Rubin,et al. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[6] K. Yanagihara,et al. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. , 2008, The Journal of antimicrobial chemotherapy.
[7] 今村 圭文. Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NCI-H292 cells , 2005 .
[8] M. Hentzer,et al. Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr−/− Mice , 2007, Antimicrobial Agents and Chemotherapy.
[9] B. A. Janowski. The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] W. Busse,et al. Increased matrix metalloproteinase-9 in the airway after allergen challenge. , 2000, American journal of respiratory and critical care medicine.
[11] S. Ohno,et al. Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release. , 2004, American journal of respiratory cell and molecular biology.
[12] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[13] H. Saito,et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. , 2000, American journal of respiratory cell and molecular biology.
[14] J. Ericsson,et al. Hyperphosphorylation regulates the activity of SREBP1 during mitosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] T. Standiford,et al. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. , 2004, American journal of respiratory and critical care medicine.
[16] A. Mankin,et al. Macrolide myths. , 2008, Current opinion in microbiology.
[17] R. Scott,et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. , 2008, American journal of respiratory and critical care medicine.
[18] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[19] E. Tagaya,et al. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections , 1995, Antimicrobial agents and chemotherapy.
[20] Y. Ichikawa,et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. , 1993, The American review of respiratory disease.
[21] P. Bozza,et al. Lipid bodies in innate immune response to bacterial and parasite infections. , 2008, International immunopharmacology.
[22] B. Rubin,et al. Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin. , 2007, The Journal of antimicrobial chemotherapy.
[23] J. Clancy,et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[24] F. Maxfield,et al. Role of cholesterol and lipid organization in disease , 2005, Nature.
[25] N. White,et al. Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. , 2004, American journal of respiratory cell and molecular biology.
[26] B. Rubin,et al. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. , 2008, Pharmacology & therapeutics.
[27] R. Boucher,et al. Cystic Fibrosis Airway Epithelial Ca2+i Signaling , 2005, Journal of Biological Chemistry.
[28] M. Brown,et al. Regulation of SREBP Processing and Membrane Lipid Production by Phospholipids in Drosophila , 2002, Science.
[29] S. Kohno,et al. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. , 1996, Respiration; international review of thoracic diseases.
[30] J. Pechère. New perspectives on macrolide antibiotics. , 2001, International journal of antimicrobial agents.
[31] T. Kohyama,et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.
[32] P. E. Van den Steen,et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.
[33] Y. Hirakata,et al. Azithromycin Inhibits MUC5AC Production Induced by the Pseudomonas aeruginosa Autoinducer N-(3-Oxododecanoyl) Homoserine Lactone in NCI-H292 Cells , 2004, Antimicrobial Agents and Chemotherapy.
[34] P. Courtoy,et al. The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: Studies on langmuir-blodgett monolayers, liposomes and J774 macrophages , 2003, The Journal of Membrane Biology.
[35] A. Prince,et al. Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. , 2005, Chest.
[36] R. Brasseur,et al. Decrease of elastic moduli of DOPC bilayers induced by a macrolide antibiotic, azithromycin. , 2007, Biochimica et biophysica acta.
[37] R. Davies,et al. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. , 1994, The European respiratory journal.
[38] D. Touw,et al. Pharmacokinetics of Azithromycin in Plasma, Blood, Polymorphonuclear Neutrophils and Sputum During Long-Term Therapy in Patients With Cystic Fibrosis , 2006, Therapeutic drug monitoring.
[39] S. Hodge,et al. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages , 2006, European Respiratory Journal.
[40] N. Matsumori,et al. Detailed description of the conformation and location of membrane-bound erythromycin a using isotropic bicelles. , 2006, Journal of medicinal chemistry.
[41] G. Silverman,et al. Intracellular and extracellular serpins modulate lung disease , 2008, Journal of Perinatology.
[42] E. Gabazza,et al. In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. , 2003, American journal of respiratory and critical care medicine.
[43] Kazuhiko Yamamoto,et al. Roxithromycin Inhibits Cytokine Production by and Neutrophil Attachment to Human Bronchial Epithelial Cells In Vitro , 1998, Antimicrobial Agents and Chemotherapy.
[44] Y. Zhen,et al. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin , 2005, Cancer Chemotherapy and Pharmacology.
[45] M. Isobe,et al. Matrix metalloproteinase suppression induced by clarithromycin in murine cardiac allografts. , 2009, Transplantation proceedings.
[46] A. Livraghi,et al. The Mitochondrial Barriers Segregate Agonist-induced Calcium-dependent Functions in Human Airway Epithelia , 2003, The Journal of general physiology.
[47] S. Sagel,et al. Induced sputum matrix metalloproteinase‐9 correlates with lung function and airway inflammation in children with cystic fibrosis , 2005, Pediatric pulmonology.
[48] H. Ceri,et al. Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. , 2000, The Journal of antimicrobial chemotherapy.
[49] R. Davies,et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. , 1995, The European respiratory journal.
[50] K. Asano,et al. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro , 2004, European Respiratory Journal.
[51] B. Rubin,et al. Clarithromycin Delays Progression of Bronchial Epithelial Cells from G1 Phase to S Phase and Delays Cell Growth via Extracellular Signal-Regulated Protein Kinase Suppression , 2006, Antimicrobial Agents and Chemotherapy.
[52] R. Boucher,et al. Chronic Airway Infection/Inflammation Induces a Ca2+i-dependent Hyperinflammatory Response in Human Cystic Fibrosis Airway Epithelia* , 2005, Journal of Biological Chemistry.
[53] Carl Alden,et al. Biomarkers to monitor drug-induced phospholipidosis. , 2007, Toxicology and applied pharmacology.
[54] S. Kohno,et al. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. , 1994, Chest.
[55] Satoshi Hachimura,et al. Growth Factor-induced Phosphorylation of Sterol Regulatory Element-binding Proteins Inhibits Sumoylation, Thereby Stimulating the Expression of Their Target Genes, Low Density Lipoprotein Uptake, and Lipid Synthesis* , 2008, Journal of Biological Chemistry.
[56] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[57] H. Saito,et al. Effect of erythromycin on matrix metalloproteinase-9 and cell migration. , 2001, The Journal of laboratory and clinical medicine.
[58] H. Mukae,et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. , 1993, The American review of respiratory disease.
[59] K. Asano,et al. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. , 2004, Mediators of inflammation.
[60] G. Verleden,et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. , 2006, American journal of respiratory and critical care medicine.
[61] M. Parnham,et al. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. , 2002, European journal of pharmacology.